Giachetti Daniela, Monti Lamberto
Dipartimento di Scienze Ambientali, Sezione di Biologia Farmaceutica, Universita degli Studi, Via Tommaso Pendola 62, 53100 Siena, Italy.
Ann Ist Super Sanita. 2005;41(1):17-22.
Plant kingdom has a wider biochemical diversity than animals and at least four-fifths of secondary metabolites come from vegetable world. This is probably due to the link between soil and plants, therefore these have to develop numerous adaptation mechanisms. To date, about 40% of modern monomolecular drugs derives directly or indirectly from plants. The phytotherapy today constitutes the most popular medical practice of complementary medicine, and in many countries its increase is continuous. Some vegetable preparations are marked as pharmaceutical regulation. However in the most cases, in absence of clinical tests, the empiric experience matured in a long period can be considered acceptable testimony of their efficacy. The vegetable products, that are used to cure smaller indications, are based on the Directive 2004/24/EC of March 2004.
植物界的生化多样性比动物界更广泛,至少五分之四的次生代谢产物来自植物界。这可能是由于土壤与植物之间的联系,因此植物必须发展出许多适应机制。迄今为止,约40%的现代单分子药物直接或间接来源于植物。如今,植物疗法是补充医学中最流行的医疗实践,在许多国家其使用量持续增加。一些植物制剂已按照药品法规进行标注。然而,在大多数情况下,由于缺乏临床试验,长期积累的经验可被视为其疗效的可接受证据。用于治疗较小病症的植物产品基于2004年3月的2004/24/EC指令。